Previous works [7, 14, 15] have conducted biomarker expression-based subtyping of gastric adenocarcinomas based on the sequential expression of EBER, MLH1, E-cadherin, and p53 and found correspondence with TCGA and ACRG molecular classifications. The gene discussed is TP53; the disease is gastric adenocarcinoma.